MedPath

A verification study for kale "Koiaona" effects on serum uric acid level regulation: a randomized, double-blinded, placebo-controlled trial.

Not Applicable
Conditions
/A(healthy adults)
Registration Number
JPRN-UMIN000035929
Lead Sponsor
Kyoto Prefectural University Of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
87
Inclusion Criteria

Not provided

Exclusion Criteria

1) Those who are receiving medication and/or treatment such as hyperuricemia or gout. 2) Those who are under treatment of diseases (urinary stone, kidney stone, rheumatoid arthritis) which may influence the outcome of the study, or diseases (urinary tract infections, renal disorders, hypertension, diabetes) that are related to the study. 3)Those who are usually taking drugs and health foods affecting the study results (e.g. Chitosan, anserine, chrysanthemum polyphenols, lactic acid bacteria PA-3, supplement containing DNA / RNA, beer yeast, health food including vegetables (vegetable enzyme drink, green juice), etc.). 4) Whose diet is extremely irregular. 5) Those who are routinely drinking a large amount of alcohol. 6) Those who are habitually exercising such as marathon. 7) Currently, exercise therapy and diet therapy are performed/ planning to under the supervision of a physician . 8) serious heart disease [heart failure, myocardial infarction, myocarditis, etc.] liver disease [liver failure symptoms (fulminant hepatitis ),patients with cirrhosis of the liver, liver tumor], renal disease [nephrotic syndrome, renal failure (acute and chronic), uremia, merged, etc. hydronephrosis] 9) Those who have participated in other clinical trials within before consent get one month, and those who are currently participating in other clinical trials. 10) At the physician's judgment, who are determined that there is a possibility that either increased risk to the subject, or sufficient data not obtained.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum uric acid level
Secondary Outcome Measures
NameTimeMethod
rine dithiocarbamates concentration, Blood carotenoid concentration, Variety and ratio of bacteria in stool, Urine uric acid level / urinary creatinine level ratio.
© Copyright 2025. All Rights Reserved by MedPath